A prospective, randomized, masked, placebocontrolled multisite clinical study of grapiprant, an EP4 Prostaglandin Receptor Antagonist (PRA), in dogs with osteoarthritis - Rausch-Derra, L; Huebner, M; Wofford, J; Rhodes, L (J Vet Intern Med, 2016)